Prebiotics and Probiotics for Gastrointestinal Disorders

Sameeha Rau,Andrew Gregg,Shelby Yaceczko,Berkeley Limketkai
DOI: https://doi.org/10.3390/nu16060778
IF: 5.9
2024-03-09
Nutrients
Abstract:The complex role of the gut microbiome in the pathogenesis of gastrointestinal (GI) disorders is an emerging area of research, and there is considerable interest in understanding how diet can alter the composition and function of the microbiome. Prebiotics and probiotics have been shown to beneficially modulate the gut microbiome, which underlies their potential for benefit in GI conditions. Formulating specific recommendations for the public regarding these dietary supplements has been difficult due to the significant heterogeneity between strains, doses, and duration of treatment investigated across studies, as well as safety concerns with administering live organisms. This review aims to summarize the existing evidence for the use of prebiotics and probiotics in various GI disorders, paying special attention to strain-specific effects that emerged and any adverse effects noted.
nutrition & dietetics
What problem does this paper attempt to address?
The paper attempts to address the issue of the application effects and mechanisms of prebiotics and probiotics in gastrointestinal diseases. Specifically: 1. **Definition and Mechanism of Action**: The paper first defines prebiotics and probiotics and explains their mechanisms of action, including how they influence human health by regulating the host immune system, improving gut barrier function, competing for pathogen nutrients and adhesion sites, and producing antimicrobial substances. 2. **Effects on Gut Permeability, Inflammation, and Nutrient Absorption**: The paper explores how prebiotics and probiotics alleviate symptoms of gastrointestinal diseases by improving gut barrier function, reducing inflammatory responses, and enhancing nutrient absorption capacity. 3. **Therapeutic Effects on Different Gastrointestinal Diseases**: The paper provides a detailed analysis of the efficacy of prebiotics and probiotics in various gastrointestinal diseases, including diarrhea (infectious diarrhea, antibiotic-associated diarrhea, Clostridium difficile infection, chemotherapy and radiotherapy-induced diarrhea), and constipation. In summary, this paper aims to summarize existing evidence, evaluate the potential therapeutic value of prebiotics and probiotics in different gastrointestinal diseases, and pay special attention to the effects of specific strains and their possible adverse reactions. This helps provide specific dietary supplement recommendations to the public and offers a reference basis for future research.